Skip to main content

Update on Immuno-Oncology Biomarkers

Tracking # 20-657695

Free

There are no ratings for this course

Learn more
Educator ASCP
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

This 1 hour, interactive, online CME/CMLE module will help pathologists, laboratory professionals, and other members of the cancer care team gain deeper scientific knowledge in immuno-oncology (IO) and keep up with the rapidly evolving science of IO biomarkers. In this module, participants will learn about evolving concepts in IO biomarker testing, including the role of tumor mutational burden (TMB). Additionally, the latest information on PD-L1 testing and interpretation for different cancers will be addressed, as well as the expanding use of checkpoint inhibitors for treatment. Learning Objectives: 1) Discuss the current and evolving role of I-O biomarkers such as PD-L1 and TMB 2) Identify the advantages and limitations of current I-O biomarker testing and interpretation methods 3) Describe the science of TMB and its potential role as a predictive I-O biomarker 4) Summarize ongoing investigational efforts to utilize biomarkers and better predict response to immune checkpoint inhibitor (CPI) therapy 5) Outline the expanding use of immune CPIs to treat different types of cancers Faculty: Robert A. Anders, MD, PhD Associate Professor, Pathology Johns Hopkins University Gastrointestinal and Liver Pathologist Johns Hopkins Hospital Feriyl Bhaijee, MD Staff Pathologist, Anatomic Pathology Ameripath The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity. These activities also meet CC Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements. ASCP designates these enduring materials for a maximum of 1.0 CMLE credit. These activities meet CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code 3-1-312-541-4848. Monday-Friday, 8:30am - 5pm Eastern Time. Method of Participation To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line. Funded by an independent educational grants from Bristol-Myers Squibb.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Molecular Pathology)

Clinical Laboratory Supervisor

1h General (Molecular Pathology)

Clinical Laboratory Technician

1h General (Molecular Pathology)

Clinical Laboratory Technologist

1h General (Molecular Pathology)

Louisiana State Board of Medical Examiners - Clinical Lab Personnel

Cytotechnologist

1h Continuing Education for Clinical Laboratory Personnel

Generalist

1h Continuing Education for Clinical Laboratory Personnel

Laboratory Assistant

1h Continuing Education for Clinical Laboratory Personnel

Phlebotomist

1h Continuing Education for Clinical Laboratory Personnel

Specialist

1h Continuing Education for Clinical Laboratory Personnel

Technician

1h Continuing Education for Clinical Laboratory Personnel

Tennessee Medical Laboratory Board

Laboratory Personnel

1h Continuing education pertaining to laboratory technology or laboratory management